send link to app

I8F-MC-GPIQ


4.4 ( 6144 ratings )
Health & Fitness Medical
Developer: Medable, Inc.
Livre

Chronic Tirzepatide Dose in the Maintenance of Body Weight Reduction in
Participants Who Have Obesity or Overweight with Weight-Related Comorbidities. This app is specifically intended for site users in the I8F-MC-GPIQ study only.